%0 Journal Article
%T Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma
%A Giuseppe Palmieri
%A Sabrina MR Satriano
%A Mario Budroni
%A Antonio Cossu
%A Francesco Tanda
%A Sergio Canzanella
%A Corrado Carac¨°
%A Ester Simeone
%A Antonio Daponte
%A Nicola Mozzillo
%A Giuseppe Comella
%A Giuseppe Castello
%A Paolo A Ascierto
%J BMC Cancer
%D 2006
%I BioMed Central
%R 10.1186/1471-2407-6-266
%X One hundred forty-nine melanoma patients with disease stage ranging from I to III were consecutively collected in 1997. A multi-marker RT-PCR assay was used on peripheral blood samples obtained at time of diagnosis and every 6 months during the first two years of follow-up (total: 5 samples). Univariate and multivariate analyses were performed after 83 months of median follow-up.Detection of at least one circulating mRNA marker was considered a signal of the presence of CMC (referred to as PCR-positive assay). A significant correlation was found between the rate of recurrences and the increasing number of PCR-positive assays (P = 0.007). Presence of CMC in a high number (¡Ư2) of analysed blood samples was significantly correlated with a poor clinical outcome (disease-free survival: P = 0.019; overall survival: P = 0.034). Multivariate analysis revealed that presence of a PCR-positive status does play a role as independent prognostic factors for overall survival in melanoma patients, adding precision to the predictive power of the disease stage.Our findings indicated that serial RT-PCR assay may identify a high risk subset of melanoma patients with occult cancer cells constantly detected in blood circulation. Prolonged presence of CMCs seems to act as a surrogate marker of disease progression or a sign of more aggressive disease.The poor prognosis of patients with malignant melanoma (MM) is mostly due to the high frequency of distant dissemination of the disease. Considering the small size of most primary melanomas, the metastatic potential of MM is considerably greater than that of most other solid tumours [1].The relationship between presence of circulating cancer cells and development of secondary disease is not fully understood. Detection of circulating malignant cells (CMCs) is actually aimed to the identification of either an earlier marker of tumour progression or a phenotypic feature of more aggressive disease that might change treatment options [2]. Detection
%U http://www.biomedcentral.com/1471-2407/6/266